- 2024-08-20 01:45抑制剂APD791|Temanogrel|887936-68-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂Apitolisib|Apitolisib|1032754-93-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:45抑制剂Apitolisib|Apitolisib|1032754-93-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂Apcin-A|Apcin-A|1683617-62-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:45抑制剂Apcin-A|Apcin-A|1683617-62-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂Apcin-A|Apcin-A|1683617-62-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂AP20187|AP20187|195514-80-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂AP20187|AP20187|195514-80-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂AOH1996|AOH1996|2089314-64-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂AOH1996|AOH1996|2089314-64-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂AP1867-2-(carboxymethoxy)|AP1867-2-(carboxymethoxy)|2230613-03-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂AP20187|AP20187|195514-80-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:45抑制剂AOH1160|AOH1160|2089314-57-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂AOH1996|AOH1996|2089314-64-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:45抑制剂AOH1160|AOH1160|2089314-57-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂AOH1160|AOH1160|2089314-57-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:45抑制剂Antineoplaston A10|Antineoplaston A10|91531-30-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂Antineoplaston A10|Antineoplaston A10|91531-30-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂Anti-inflammatory agent 34|Anti-inflammatory agent 34|867301-81-3|Adamas life|≥98%（以实测数值为准）|BR|25
- 2024-08-20 01:45抑制剂Anti-inflammatory agent 34|Anti-inflammatory agent 34|867301-81-3|Adamas life|≥98%（以实测数值为准）|BR|5m
